Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1000 participants.
Also called NCT03755700
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 1,000 participants
- Registry
-
NCT03755700
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Iran
- Registry status
- Unknown status
Technical summary
Registry record NCT03755700. Randomized; double masking; primary purpose prevention. Start 2018-11-01 (actual); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization
- Condition
- Coronary Artery Disease
- Condition
- Coronary Artery Angiography
- Condition
- Coronary Catheterization
- Condition
- Contrast-induced Nephropathy
- Condition
- Stable Angina
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Vitamin E
- Intervention (Drug)
- N-acetyl cysteine
- Intervention (Drug)
- Placebo oral capsule
- Intervention (Drug)
- Placebos
- Intervention (Drug)
- Normal Saline Flush, 0.9% Injectable Solution
- Lead sponsor
- Rajaie Cardiovascular Medical and Research Center
Record details
- Record id
cardio:ct-nct03755700- Content hash
f4684e3afcc5abbd4ef6885e88c574994d66d8b285b75f60da39c90e7a50ed02